SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,767.57 238.50
( 0.33%)

Global Indices

Nasdaq

51,369.65 -132.86
(-0.26%)

Dow Jones

7,690.99 -13.70
(-0.18%)

Hang Seng

66,863.07 1,381.80
(2.11%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.96 0.17
(0.18%)

EUR-INR

109.15 0.06
(0.06%)

GBP-INR

127.16 0.33
(0.26%)

JPY-INR

0.61 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

16.95

15115.98

EPS(TTM)

Face Value()

Div & Yield %

49.8

0.59

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	3594.60	4094.50	3568.90	2351.00	1767.80	1653.50
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	3594.60	4094.50	3568.90	2351.00	1767.80	1653.50
Other Income	281.10	321.30	104.70	85.50	94.60	101.10
Stock Adjustments	69.20	-11.60	-17.20	-34.60	5.50	46.90
Total Income	3944.90	4404.20	3656.40	2401.90	1867.90	1801.50
EXPENDITURE :
Raw Materials	642.90	581.70	557.30	495.10	540.10	546.90
Power & Fuel Cost	96.90	93.10	88.90	81.90	76.40	59.40
Employee Cost	591.70	515.30	454.90	425.70	410.10	380.00
Other Manufacturing Expenses	279.90	217.70	179.80	150.30	148.70	114.30
Selling & Administrative Expenses	618.50	444.10	483.70	290.70	309.10	140.30
Miscellaneous Expenses	129.00	86.70	150.10	28.00	75.90	41.90
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	2358.90	1938.60	1914.70	1471.70	1560.30	1282.80
Operating Profit	1586.00	2465.60	1741.70	930.20	307.60	518.70
Interest	32.30	19.60	14.50	8.60	13.30	11.30
Gross Profit	1553.70	2446.00	1727.20	921.60	294.30	507.40
Depreciation	189.60	220.00	171.90	150.90	138.40	115.20
Profit Before Tax	1364.10	2226.00	1555.30	770.70	155.90	392.20
Tax	268.40	407.50	284.80	133.10	32.50	93.30
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-185.80	-31.90	-36.10	0.50	-15.70	-10.60
Reported Net Profit	1281.50	1850.40	1306.60	637.10	139.10	309.50
Extraordinary Items	-18.23	104.58	-2.12	14.71	33.80	24.39
Adjusted Net Profit	1299.73	1745.82	1308.72	622.39	105.30	285.11
Adjustment below Net Profit	15.30	3.00	-49.70	-1.00	0.40	2.20
P & L Balance brought forward	5972.20	4226.30	3134.60	2587.10	2520.50	2322.50
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	89.60	107.50	165.20	88.60	72.90	113.90
P & L Balance carried down	7179.40	5972.20	4226.30	3134.60	2587.10	2520.30
Dividend	0.00	0.00	170.20	100.40	82.10	113.90
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	250.00	300.00	475.00	275.00	225.00	262.50
Dividend Per Share(Rs)	5.00	6.00	9.50	5.50	4.50	5.25
Earnings Per Share-Unit Curr	71.59	103.37	72.99	34.91	7.62	16.96
Earnings Per Share(Adj)-Unit Curr	71.59	103.37	72.99	34.91	7.62	16.96
Book Value-Unit Curr	477.80	409.72	312.42	257.64	229.69	224.17
Book Value(Adj)-Unit Curr	477.80	409.72	312.42	257.64	229.69	224.17

72,767.57 238.50 ( 0.33%)

51,369.65 -132.86 (-0.26%)

7,690.99 -13.70 (-0.18%)

66,863.07 1,381.80 (2.11%)

10,628.22 -56.66 (-0.53%)

95.96 0.17 (0.18%)

109.15 0.06 (0.06%)

127.16 0.33 (0.26%)

0.61 0.00 (0.14%)